RIGL Deferred Revenue
Rigel Pharmaceuticals Inc · Deferred Revenue
RIGL Deferred Revenue
Latest reported$1.36Mperiod ending
RIGL FY Deferred Revenue ($0.00 → $1.36M)
Annual deferred revenue
High-resolution chart · PNG
RIGL deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 1,355,000 | |
| 27,795,000 | |
| 17,039,000 | |
| 13,514,000 | |
| 10,511,000 | |
| 3,018,000 | |
| 25,288,000 | |
| 1,030,000 | |
| -284,000 | |
| -3,222,000 | |
| 13,427,000 | |
| -2,803,000 | |
| 0 | |
| 666,000 | |
| 129,000 | |
| -755,000 | |
| -1,061,000 | |
| 3,174,000 | |
| 10,164,000 | |
| 3,066,000 | |
| 15,567,000 | |
| 3,728,000 | |
| 2,242,000 | |
| 4,061,000 | |
| 3,264,000 | |
| 2,370,000 | |
| 0 |